We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

160 hedge funds and large institutions have $176M invested in Emergent Biosolutions in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 40

25% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 28

3% more funds holding

Funds holding: 156 → 160 (+4)

2.48% more ownership

Funds ownership: 64.13% → 66.6% (+2.5%)

1% less call options, than puts

Call options by funds: $944K | Put options by funds: $956K

47% less capital invested

Capital invested by funds: $332M → $176M (-$156M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
160
Holders Change
+4
Holders Change %
+2.56%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
35
Increased
53
Reduced
40
Closed
28
Calls
$944K
Puts
$956K
Net Calls
-$12K
Net Calls Change
-$2.62M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$8.45M
2
LSV Asset Management
LSV Asset Management
Illinois
+$6.7M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$5.23M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.08M
5
PGCM
Prescott Group Capital Management
Oklahoma
+$3.46M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$6.56M
2
Charles Schwab
Charles Schwab
California
-$5.85M
3
Two Sigma Investments
Two Sigma Investments
New York
-$3.72M
4
Morgan Stanley
Morgan Stanley
New York
-$2.98M
5
State Street
State Street
Massachusetts
-$2.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$1.93M -$3.72M -449,966 -53%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$1.82M +$569K +68,748 +22%
VFA
28
Values First Advisors
Tennessee
$1.81M -$12K -1,445 -0.4%
Cetera Investment Advisers
29
Cetera Investment Advisers
Illinois
$1.73M +$654K +79,034 +29%
Truist Financial
30
Truist Financial
North Carolina
$1.63M +$2.07M +250,236 +294%
Citadel Advisors
31
Citadel Advisors
Florida
$1.43M +$1.19M +144,090 +96%
Federated Hermes
32
Federated Hermes
Pennsylvania
$1.36M +$11K +1,331 +0.5%
HF
33
HRT Financial
New York
$1.34M +$2.28M +275,716 New
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$1.32M -$917K -110,769 -29%
Squarepoint
35
Squarepoint
New York
$1.11M +$1.5M +180,718 +383%
SSA
36
Schonfeld Strategic Advisors
New York
$1.04M +$562K +67,949 +47%
JP Morgan Chase
37
JP Morgan Chase
New York
$1.04M +$1.77M +213,313 +49,150%
Jacobs Levy Equity Management
38
Jacobs Levy Equity Management
New Jersey
$954K +$91.6K +11,067 +6%
MAM
39
Morse Asset Management
Connecticut
$911K +$237K +28,645 +18%
Fidelity Investments
40
Fidelity Investments
Massachusetts
$794K +$183K +22,068 +16%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$771K +$1.31M +158,100 +27,026%
Northern Trust
42
Northern Trust
Illinois
$723K +$24.1K +2,913 +2%
Fuller & Thaler Asset Management
43
Fuller & Thaler Asset Management
California
$717K -$71.1K -8,585 -6%
OAC
44
OMERS Administration Corp
Ontario, Canada
$713K +$948K +114,500 +356%
Wellington Management Group
45
Wellington Management Group
Massachusetts
$695K +$63.1K +7,624 +6%
Deutsche Bank
46
Deutsche Bank
Germany
$674K – – –
WAM
47
Wolverine Asset Management
Illinois
$663K – – –
Barclays
48
Barclays
United Kingdom
$546K +$147K +17,788 +19%
Rafferty Asset Management
49
Rafferty Asset Management
New York
$540K -$278K -33,620 -23%
SFI
50
Susquehanna Fundamental Investments
Pennsylvania
$526K +$79.3K +9,579 +10%
1
2
3 4 5

EBS Hedge Fund Activity: Q1 2025 in Review

160 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2025, worth a combined $176M — down 47% from $332M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new EBS positions and 28 closed out — a net gain of 7 holders — while 53 added to existing stakes and 40 trimmed.

The largest buyer was Millennium Management, adding an estimated $8.45M. The largest seller was Invesco, cutting an estimated $6.56M.

  • 160 institutional investors held Emergent Biosolutions (EBS) as of Q1 2025, up from 156 in Q4 2024.
  • Funds reported $176M of Emergent Biosolutions stock for Q1 2025, down 47% quarter-over-quarter.
  • 35 funds opened new Emergent Biosolutions positions in Q1 2025 and 28 closed out, a net change of +7 holders.
  • The largest Emergent Biosolutions buyer in Q1 2025 was Millennium Management, an estimated $8.45M added.
  • The largest Emergent Biosolutions seller in Q1 2025 was Invesco, an estimated $6.56M sold.

Based on aggregated 13F filings for Q1 2025.